The Lawson family in Yukon has spent eight years raising awareness for Angelman syndrome, a rare genetic disorder, while ...

The company expects top line data from the study in the second half of 2027.

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that it has completed enrollment in the pivotal cohort (Cohort 1) ...

Add Yahoo as a preferred source to see more of our stories on Google. The rare neurogenetic disorder affects 1 in 15,000 people For the first time, Colin Farrell has opened up his home and talked ...

Angelman syndrome is a rare neurodevelopmental disorder characterized by changes in brain structure, severe intellectual disability, impairments in speech, motor function, epilepsy, sleep, and unique ...

Ionis Pharmaceuticals IONS announced that it has completed enrollment in cohort 1 of the phase III REVEAL study, which is ...

Colin Farrell revealed that his 20-year-old son, James, has been living with a disorder known as Angelman Syndrome. While speaking with PEOPLE in a recent interview, the Saving Mr. Banks star, 48, ...

Angelman syndrome has no cure and few treatments but the rare genetic disorder now has the first clinic in the nation dedicated to the condition. The University of North Carolina at Chapel Hill has ...

For the first time, the Brazilian Football Confederation (CBF) joins Angelman Brasil in a national awareness campaign about Angelman Syndrome, a rare and still little-known genetic condition. The ...

A new review sheds light on the complex molecular mechanisms behind Angelman syndrome (AS), a rare neurogenetic disorder, and explores how cutting-edge gene-targeting therapies may offer more ...

The authors showed that both membrane depolarization and glutamate receptor activation increased the levels of UBE3A mRNA and protein in cultured neurons and in the brains of mice housed in an ...